Target intelligence / Profile preview

RNA, U6 small nuclear 226, pseudogene (RNU6-226P)

Target
RNU6-226P
Molecular classification
Other (processed non-coding RNA pseudogene)
01

Overview

RNA, U6 small nuclear 226, pseudogene (RNU6-226P) refers to a pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. U6 snRNA serves as an essential component of the spliceosome, the molecular machinery responsible for removing introns from pre-mRNA in eukaryotic cells[1]. Pseudogenes such as RNU6-226P are non-functional genomic copies, typically generated by retrotransposition events mediated by LINE retroelements, most commonly LINE-1 (L1); they lack the full functionality of the parent U6 snRNA gene because of accumulated mutations, truncations, or integration in non-transcribed regions[2][4]. The U6 pseudogenes do not participate in RNA splicing and are generally considered "genomic fossils" that typically serve no known biological function or drug target role, though they can be used as markers to study retrotransposon dynamics in the genome[2][4]. There is no evidence of interaction with drugs, biomarker potential, or involvement in any recognized disease process.

Other names
RNU6-226PU6 snRNA pseudogene 226U6 small nuclear RNA pseudogene 226
02

Biological functions

None (pseudogene; does not encode a functional RNA)
03

Disease associations

Other (no direct disease association; not established as pathogenic)

Beyond the preview

Go deeper on RNA, U6 small nuclear 226, pseudogene (RNU6-226P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 226, pseudogene (RNU6-226P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call